Medtronic Announces Full-Portfolio Win of Peripheral Arterial Stents in China's Fifth Round National Volume-Based Procurement

中标！

On December 19, in the "Fifth Batch of National Organized Cochlear Implants and Peripheral Vascular Stents Medical Consumables Volume-based Procurement," the full range of peripheral lower limb artery and carotid artery stent products from the former Coviden Medical Devices International Trade (Shanghai) Co., Ltd. (now integrated into Medtronic) successfully won the bid.

Over the past 35 years of Medtronic's deep engagement in the Chinese market, adhering to the corporate mission of "alleviating pain, restoring health, and extending life," it has consistently been committed to providing more reliable and efficient treatment solutions through advanced technology and high-quality products, helping patients improve their quality of life and reduce the burden of disease.

With the implementation of China's national peripheral stent centralized procurement policy, Medtronic will continue to adhere to a patient-centered approach, strengthen cooperation with medical institutions at all levels, follow national policy guidelines, optimize product costs, ensure product quality and market supply, focus on research and development, and continuously inject new opportunities and vitality into promoting the healthy development of the industry.